Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 21, 2017
Prominent differences in left ventricular performance and myocardial properties between right ventricular and left ventricular-based pacing modes in ratsWesam Mulla, Sharon Etzion, Sigal Elyagon, et al.
Frontiers in Physiology|July 28, 2018
Unanesthetized Rodents Demonstrate Insensitivity of QT Interval and Ventricular Refractory Period to Pacing Cycle LengthWesam Mulla, Roni Gillis, Michael Murninkas, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 18, 2020
A new implantable tool for repeated assessment of supraventricular electrophysiology and atrial fibrillation susceptibility in freely moving ratsMichael Murninkas, Roni Gillis, Danielle I Lee, et al.
Frontiers in Physiology|October 17, 2019
Rapid Atrial Pacing Promotes Atrial Fibrillation Substrate in Unanesthetized Instrumented RatsWesam Mulla, Barak Hajaj, Sigal Elyagon, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2021
The impact of osimertinib' line on clonal evolution in EGFRm NSCLC through NGS-based liquid biopsy and overcoming strategies for resistanceVered Fuchs, Laila Roisman, Waleed Kian, et al.
Cancers|May 4, 2026
The Impact of Minimal Residual Disease (MRD) Testing on the Decision-Making Process in Non-Small-Cell Lung Cancer (NSCLC)Roni Gillis, Tamar Zahavi, Nir Peled, et al.
Journal of Racial and Ethnic Health Disparities|March 8, 2024
Jerusalem's CoVID-19 Experience-The Effect of Ethnicity on Disease Prevalence and Adherence to TestingMichael Sorotzky, Allon Raphael, Adin Breuer, et al.
Lung Cancer (Amsterdam, Netherlands)|June 7, 2025
Lurbinectedin for extensive stage - small cell lung cancer (ES-SCLC): real world response patterns and survival outcomesBelal Krayim, Walid Shalata, Jair Bar, et al.
Science Advances|September 12, 2020
Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriersNoam Shental, Shlomia Levy, Vered Wuvshet, et al.
Lung Cancer (Amsterdam, Netherlands)|August 18, 2020
GLASS: Global Lorlatinib for ALK(+) and ROS1(+) retrospective Study: real world data of 123 NSCLC patientsNir Peled, Roni Gillis, Saadettin Kilickap, et al.
Pageof 3